The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
The complexity of targeting EGFR signalling in cancer: From expression to turnover
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–222 of 222
Lombardo, C. R., Consler, T. G., & Kassel, D. B. (1995) · Biochemistry · doi:10.1021/bi00050a029 · Cited by 63
The epidermal growth factor receptor: A new target for anticancer therapy
Grünwald, V., & Hidalgo, M. M. (2002) · Current Problems in Cancer · doi:10.1067/mcn.2002.125874 · Cited by 61
Huang, G. C., Ouyang, X., & Epstein, R. J. (1998) · Biochemical Journal · doi:10.1042/bj3310113 · Cited by 57
Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent.
Castagnino, P. A., Biesová, Z., Wong, W. T., et al. (1995) · PubMed · Cited by 57
Steinbach, J. P., Eisenmann, C., Klumpp, A., & Weller, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.175 · Cited by 56
Azzariti, A., Xu, J.-M., Porcelli, L., & Paradiso, A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.014 · Cited by 53
Self-citationTherapeutics targeting signal transduction for patients with colorectal carcinoma
Bono, J. S. D., & Rowinsky, E. K. (2002) · British Medical Bulletin · doi:10.1093/bmb/64.1.227 · Cited by 53
Arteaga, C. L. (2003) · Breast Cancer Research · doi:10.1186/bcr574 · Cited by 52
Li, H., & Villalobo, A. (2002) · Biochemical Journal · doi:10.1042/bj3620499 · Cited by 47
Salvatori, L., Ravenna, L., Felli, M. P., Cardillo, M. R., Russo, M. A., Frati, L., Gulino, A., & Petrangeli, E. (2000) · Endocrinology · doi:10.1210/endo.141.6.7521 · Cited by 43
Johannessen, L. E., HAUGEN, K. E., Østvold, A. C., Stang, E., & Madshus, I. H. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3560087 · Cited by 40
Sorkin, A. D., Eriksson, A. B., Heldin, C., Westermark, B., & Claesson, L. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041560221 · Cited by 40
Molecular chaperones in cilia and flagella: Implications for protein turnover
Stephens, R. E., & Lemieux, N. A. (1999) · Cell Motility and the Cytoskeleton · doi:10.1002/(sici)1097-0169(199912)44:4<227::aid-cm1>3.0.co;2-b · Cited by 39
Nakamura, H., Takamori, S., Fujii, T., Ono, M., Yamana, H., Kuwano, M., & Shirouzu, K. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.12.020 · Cited by 37
Anti-EGFR–mediated radiosensitization as a result of augmented EGFR expression
Bonner, J. A., Buchsbaum, D. J., Russo, S. M., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.01.053 · Cited by 36
Wang, Y., Pennock, S., Chen, X., & Wang, Z. (2002) · Science s STKE · doi:10.1126/stke.2002.161.pl17 · Cited by 32
EGFR inhibitors in lung cancer.
Buter, J., & Giaccone, G. (2005) · PubMed · Cited by 24
TGF-α-Driven Tumor Growth Is Inhibited by an EGF Receptor Tyrosine Kinase Inhibitor
El‐Obeid, A., Hesselager, G., Westermark, B., & Nistér, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6210 · Cited by 20
Recchia, F., Saggio, G., Cesta, A., et al. (2005) · PubMed · Cited by 19
Choi, J. H., Hong, W.-P., Yun, S., Kim, H. S., Lee, J.-R., Park, J. B., Bae, Y. S., Ryu, S. H., & Suh, P. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.01.005 · Cited by 18
Solution and solid state conformation of the human EGF receptor transmembrane region
Rigby, A. C., Grant, C. W. M., & Shaw, G. S. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00020-0 · Cited by 16
Overcoming Acquired Resistance to Iressa/Tarceva with Inhibitors of a Different Class
Haber, D. A., & Settleman, J. E. (2005) · Cell Cycle · doi:10.4161/cc.4.8.1874 · Cited by 13
Self-citation
Cited by
Systems-level interactions between insulin–EGF networks amplify mitogenic signaling
Borisov, N., Aksamitiene, E., Kiyatkin, A., Legewie, S., Berkhout, J., Maiwald, T., Kaimachnikov, N. P., Timmer, J., Hoek, J. B., & Kholodenko, B. N. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.19 · Cited by 222
Elevated concentration of microvesicles isolated from peripheral blood in breast cancer patients
Galindo-Hernandez, O., Villegas-Comonfort, S., Candanedo, F., González-Vázquez, M.-C., Chavez-Ocaña, S., Jimenez-Villanueva, X., Sierra-Martinez, M., & Salazar, E. P. (2013) · Archives of Medical Research · doi:10.1016/j.arcmed.2013.03.002 · Cited by 152
Kong, L., Deng, Z., Shen, H., & Zhang, Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0632-1 · Cited by 41
In vitro combined treatment with cetuximab and trastuzumab inhibits growth of colon cancer cells
Luca, T., Barresi, V., Privitera, G., Musso, N., Caruso, M., Condorelli, D. F., & Castorina, S. (2014) · Cell Proliferation · doi:10.1111/cpr.12125 · Cited by 27
Odin (ANKS1A) Modulates EGF Receptor Recycling and Stability
Tong, J., Sydorskyy, Y., St-Germain, J. R., Taylor, P., Tsao, M. S., & Moran, M. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064817 · Cited by 25
Metadata
- Authors
- Sebastian, S., Settleman, J., Reshkin, S. J., Azzariti, A., Bellizzi, A., & Paradiso, A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 1766
- Issue
- 1
- Pages
- 120-139
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2082827206
- Cited by
- 260
- References
- 222
- FWCI
- 10.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.